Back to BlackRock, Inc. BlackRock, Inc.

TENXTENX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Tenax Therapeutics, Inc.

BlackRock, Inc. holds 1.7M shares of TENX (Tenax Therapeutics, Inc.), worth $25.1M as of 2026-Q2. The position was increased (+101x shares). TENX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$25.1M

Current Shares

1.7M

Total Value Change

+$25.1M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+101x
$25.1M0.0%$14.55
46
2026-Q1
Increased
16,977
+1.6%
$271,4620.0%$11.42
16
2025-Q4
Increased
16,714
+5452.8%
$203,7440.0%$12.00
25
2025-Q3
Increased
301
+0.3%
$2,2910.0%$7.28
8
2025-Q2
Unchanged
300
0.0%
$1,7280.0%$5.85
0
2025-Q1
Unchanged
300
0.0%
$1,9650.0%$6.49
0
2024-Q4
New
300
-
$1,8570.0%$6.55
17

Other major holders of TENX: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Janus Henderson Group Ltd., VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used